Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive Factors.

[1]  S. Devireddy,et al.  Sympathetic ophthalmia: a review of literature. , 2012, Oral surgery, oral medicine, oral pathology and oral radiology.

[2]  T. Hirose,et al.  Vogt-Koyanagi-Harada Syndrome: Review of Clinical Features , 2011, Seminars in ophthalmology.

[3]  L. Young,et al.  Sympathetic Ophthalmia , 2011, Seminars in ophthalmology.

[4]  A. Gaudric,et al.  Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt–Koyanagi–Harada disease , 2011, Acta ophthalmologica.

[5]  M. Bordaberry.  Vogt–Koyanagi–Harada disease: diagnosis and treatments update , 2010, Current opinion in ophthalmology.

[6]  J. Kempen,et al.  Adverse effects of smoking on patients with ocular inflammation , 2010, British Journal of Ophthalmology.

[7]  M. Khairallah,et al.  Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. , 2010, Ophthalmology.

[8]  J. Kempen,et al.  Azathioprine for ocular inflammatory diseases. , 2009, American journal of ophthalmology.

[9]  M. Hangai,et al.  Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography. , 2009, Ophthalmology.

[10]  D. Agrawal,et al.  Posterior scleritis presenting with simultaneous branch retinal artery occlusion and exudative retinal detachment , 2009, Eye.

[11]  B. Oum,et al.  Edema of the Photoreceptor Layer in Vogt-Koyanagi-Harada Disease Observed Using High-Resolution Optical Coherence Tomography , 2009, Korean journal of ophthalmology : KJO.

[12]  J. Kempen,et al.  Methods for Identifying Long-Term Adverse Effects of Treatment in Patients with Eye Diseases: The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study , 2008, Ophthalmic epidemiology.

[13]  Stephen W Lagakos,et al.  Statistics in medicine--reporting of subgroup analyses in clinical trials. , 2007, The New England journal of medicine.

[14]  N. Rao,et al.  Pathology of Vogt–Koyanagi–Harada disease , 2007, International Ophthalmology.

[15]  Douglas A Jabs,et al.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. , 2005, American journal of ophthalmology.

[16]  R. Nussenblatt.  The natural history of uveitis , 1990, International Ophthalmology.

[17]  I. McLean,et al.  Atypical histopathologic features in sympathetic ophthalmia , 1982, International Ophthalmology.

[18]  J. Piette,et al.  Chronic Severe Uveitis: Etiology and Visual Outcome in 927 Patients from a Single Center , 2001, Medicine.

[19]  J. Haybittle,et al.  Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. , 1999, Ophthalmology.

[20]  J. Loewenstein,et al.  Systemic Diseases Manifesting as Exudative Retinal Detachment , 1998, International ophthalmology clinics.

[21]  A. Rothova,et al.  Causes and frequency of blindness in patients with intraocular inflammatory disease. , 1996, The British journal of ophthalmology.

[22]  W. E. Benson,et al.  Posterior scleritis. , 1988, Survey of ophthalmology.

[23]  R. Nussenblatt,et al.  International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. , 1987, American journal of ophthalmology.

[24]  D. Albert,et al.  Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of 105 cases (1913--1978). , 1980, Ophthalmology.